JINGHUA PHARM released its first-quarter performance, with a net profit attributable to the parent company of 62.2197 million yuan, a decrease of 12.47%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, JINGHUA PHARM (002349.SZ) released its first-quarter report for 2025, showing an operating income of 364 million yuan, a year-on-year decrease of 0.98%. The net profit attributable to shareholders of the listed company was 62.2197 million yuan, a year-on-year decrease of 12.47%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 60.3491 million yuan, a year-on-year decrease of 8.30%. The basic earnings per share were 0.0764 yuan

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.